Science

Jul 23, 2025, 09:06

Myeloma Paper of the Day, July 23rd, Suggested by Robert Orlowski

Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day:

Single-center experience of long-term outcomes of AL amyloidosis patients receiving heart transplant finds 1-, 3-, 5-, and 8-year survival (87%, 83%, 73%, and 67%) not different vs. non-AL patients (92%, 85%, 79%, 68%).”

Title: Long-term outcomes of light chain amyloidosis patients receiving heart transplant: A single-center experience

Authors: Khush Patel, Zoe H. Tu, Carrie Yuen, Siddhartha Ganguly, Allison N. Yun, Janardhana R. Gorthi, Barry H. Trachtenberg, Ashrith Guha, Mahwash Kassi, Ju Kim, Rayan Yousefzai, Kelty Baker, Lawrence Rice, Rammurti T. Kamble, Horacio E. Adrogue, Erik E. Suarez, Mark Ghobrial, Ashish Saharia, Constance M. Mobley, David W. Victor, Jill C. Krisl, Richard Knight, A. Osama Gaber, Arvind Bhimaraj.

You can read the Full Article in JHLT Open.

Myeloma Paper of the Day, July 23rd, Suggested by Robert Orlowski

You can find more posts featuring Robert Orlowski in OncoDaily.

A. Osama Gaber AL Amyloidosis Allison N. Yun Arvind Bhimaraj Ashish Saharia Ashrith Guha Barry H. Trachtenberg cancer Carrie Yuen Constance M. Mobley David W. Victor Erik E. Suarez Horacio E. Adrogue Janardhana R. Gorthi Jill C. Krisl Ju Kim Kelty Baker Khush Patel Lawrence Rice Mahwash Kassi Mark Ghobrial Myeloma Myeloma Paper of the Day OncoDaily Oncology Rammurti T. Kamble Rayan Yousefzai Richard Knight Robert Orlowski Siddhartha Ganguly Zoe H. Tu

FDA Accepts NDA for Vepdegestrant in ESR1-Mutant ER+/HER2- Advanced Breast Cancer

Hubert Caron Retires from Roche-Genentech

Ramy Sedhom: Palliative Care Isn’t Just about When. It’s about Who, What, and How

Miriam Mutebi: One Small Grant, One Big Difference

Jasmine Kamboj: How We Bring Ourselves to the Table as Leaders